CD274 and acute kidney injury: Given this role in controlling inflammation, and the observation of AKI in the clinical setting due to ICI therapies, PD-1/PD-L1 targeting therapies, in conjunction with nephrotoxic drugs (such as the widely used cisplatin), need to be critically evaluated to avoid unintended kidney injury.